6
Most read
11
Most read
18
Most read
Heart Failure
Prepared by:
malek ahmad
University of Malaya
Outline
Definition and Epidemiology
Pathophysiology
Aetiological factors and Risk factors
Clinic al manifestation
Investigation
Differential diagnosis
Management and treatment
Complication and prognosis
Definition
• Inability in which heart cannot
provide sufficient cardiac output
to vital organ to satisfy the
metabolic body needs or only
can do so with filling pressure
are higher than normal
• Due to any structural or
functional cardiac abnormalities
• Can be divided to LVF , RVF
• Always cause circulatory failure
Epidemiology
• Num 1 cause of
hospitalization among
Medicare patients
• Cause more hospitalization
than all form of cancer
combined
Heart Failure
Heart Failure
Terms
• Deterioration of myocardial contraction function
Systolic dysfunction
• Normal contraction but abnormal relaxation
Diastolic dysfunction
• Inadequate CO
Forward failure
• Congestion of venous system
Backward failure
• Low CO and fails to increase normally with exertion
Low-output failure
• Greatly increase tissue demands result to failure
High-output failure
• Dilated ventricle able to maintain CO at level that meets
body needsCompensated HF
• Dilated ventricle unable to maintain and propel sufficient
blood at level that meets body needsDecompensated HF
Pathophysiology
Reduced
myocardial
contractility
Increase
haemodynamic
burden
Heart failure
Mechanism of adaptation
• SNS>NA>Incrs HR, Incrs contractality, VasoC
• Activation of RAAS
• ANP>VasoD, natriuresis, diuresis
Activation of
neurohormonal
system
• Incrs EDV> Incrs EDP > muscle fibers strech > Incrs cardiac
chamber V > contract more forcibly
• However, incrs dilatation>incrs ventricular wall tension
>incrs O2 demand
Frank-starling
mechanism
(heamodynamic
changes)
• Pressure overload>incrs fiber diameter>concenteric
hyperthrophy (incrs wall thckness w/o incrs chamber size)
• Volume overload>incrs fiber length>eccenteric
hyperthrophy>incrs heart size, incrs wall thickness
Myocardial
structural changes
(cellular)
Aetiological causes
• Structural abnormalities (congenital /acquired) that
affect the circulation, pericardium, myocardium,
valves.
Underlying causes
• Biochemical n physiological mechanism, increased
(increased hemodynamic burden n reduce
O2delivery)
Fundamental causes
Precipitating causes
Underlying causes
• CAD , DM , HPT , VHD , arrythmias, infection n
inflamation, conegital , drug induced , idiopathicSystolic heart failure
• CAD , DM , HPT , VHD , hyperthropic cardiomyopathy,
restrictive cardiomyopathy (amyloidosis) , pericarditisDiastolic heart failure
• Acute MR/AR , MI , Myocarditis , arrythmias, drugs
induced , sepsisAcute heart failure
• Anemia, hyperthyroid, pagets, GN, multiple myoloma,
carcinoid syndrome, polychaethemia vera
High output heart
failure
• LVD , CAD , pulmonary HPT , PS , pulmonary embolism ,
chronic pulmonary disease , neuromuscular dsRight heart failure
Precipitating causes
Recurrent or continued
coronary ischaemia
Recurrent myocardial
infarction
Hypokalaemia,
hypomagnesaemia,
hyperkalaemia
Psychotropic drugs-for
example, tricyclic
antidepressants
Digoxin (leading to
toxicity)
Antiarrhythmic drugs
that may be
cardiodepressant
(negative inotropism)
and proarrhythmic
Left heart failure
IHD
Systemic HPT
Mitral/aortic valve disease
Primary disease of myocardium
Right heart failure
LHF
Pulmonary congestion
Elevation of pulmonary
arterial pressure
•Intrinsic disease of lung
parenchyma and/ or pulmonary
vasculature (cor pulmonale)
•Primary pulmonic/ tricuspid
valve disease
•Congenital-L to R shunt
Isolated
RHF
NYHA classification of HF
•No limitation in physical activity despite presence of heart disease.
This can be suspected only if there is a history of heart disease which
is confirmed by investigations - for example, echocardiography
Class I:
asymptomatic
•Slight limitation in physical activity. More strenuous activity causes
shortness of breath - for example, walking on steep inclines and
several flights of steps. Patients in this group can continue to have an
almost normal lifestyle and employment
Class II: mild
•More marked limitation of activity which interferes with work.
Walking on the flat produces symptoms
Class III:
moderate
•Unable to carry out any physical activity without symptoms. Patients
are breathless at rest and mostly houseboundClass IV: severe
Clinical manifestation
Left Heart failure
Dyspnoea
Cough- fluid transudation onto airspace
Orthopnoea-increase Venous Return
PND
Others-cadiomegaly,tachy,s3, fine rales
(respiration thru edematous pulmonary
alveoli, MR, systolic murmur, AF
Right heart failure
Systemic and portal venous
congestion
Hepatosplenomegaly
Peripheral edema
Pleural effusion
Ascites
Differential diagnosis
ARDS
Cardiogenic
shock
COPD
MI Pneumonia
Pneumothorax
Pulmonary
edema /
embolism
Respiratory
failure
Emphysema
Framingham Systems
major
PND , neck vein distyensiom
Rales, cardiomegaly
S3 gallop, acute PE
CVP greater than 16cm H2O
Hepatojugular reflux
PE, visceral congestion
Weight loss 4.5 in 5d
minor
Bilateral ankle edema
Nocturnal cough
Dyspnoea on ordinary exertion
tachycardia
Pleural effusion
To diagnose HF = 2major
/ 1major+2minor
Investigation
• Established baselineFBC , electrolyte(K+) ,
RFT, LFT
• Biomarker for heart failure and reflects the myocyte
stretch and exclude other diagnosisBNP
• Alveolar oedema, kerley B lines , cardiomegaly,
dilated upper lobe vessels , pleural effusionCRX
• Indicate the cause
• Confirm the presence or absence of LV dysfunctionEcho
• Indicate the cause, look sign of ischemia, MI ,
ventricular hyperthrophyECG
Management and treatment
Acute heart failure
Sit upright
O2n 100% if no lung
disease
IV acces and monitor
ECG treat arrythmia
Ix and dimorphine ,
frusemide , GTN spray
Necessary IX, history
and examination
Chronic heart failure
Stop smoking, eat less salt, optimize weight n nutrition
Treat cause (arrhythmia, valve disease)
Treat exacerbating factor s(anemia , thyroid disease)
Avoid exacerbating factors, NSAIDs
• Diuretics- furosemide, spironolactone
• ACE inhibitor – angitensin receptor blocker
• B-blocker – carvedilol
• Digoxin
• Vasodilator - hydralazine
Drugs
Complication
• Unintentional rapid weight loss (a
loss of at least 7.5% of normal
weight within 6 months)
Cardiac cachexia
• Due to poor blood supply
Impaired kidney
function
• Malabsorption
• Hepatic congestion and dysfunction
GIT
• AF, ventricular arrhythmiasArrhythmias
• Stroke, peripheral and pulmonary
embolism, DVT,
Thromboembolism
Prognosis
Better in asymptomatic left
ventricular dysfunction
than that in those whose
left ventricular dysfunction
is symptomatic.
NYHA class, left ventricular
ejection fraction, and
neurohormonal status
Dependent on severity,
age, and sex, with a poorer
prognosis in male patients
Predictor of poor prognosis
High NYHA functional class
Reduced left ventricular ejection fraction
Raised plasma catecholamine and natriuretic peptide
concentrations, Reduced sodium concentration
Third heart sound
Diabetes mellitus

More Related Content

PPT
PPTX
PPT
Right and left ventricular hypertrophy
PPTX
Approach to heart failure medicos notes-com
PPTX
Congenital heart disease
DOC
Right and Left Congestive Heart Failure
PPT
Cardiomyopathy
PPT
Management of Cardiogenic shock
Right and left ventricular hypertrophy
Approach to heart failure medicos notes-com
Congenital heart disease
Right and Left Congestive Heart Failure
Cardiomyopathy
Management of Cardiogenic shock

What's hot (20)

PPT
Pulmonary hypertension
PPTX
Heart failure
PPSX
Heart failure
PPTX
Heart failure: Basic Cocepts
PPT
Heart Failure
PPTX
Heart failure
PPTX
Heart failure management
PPTX
Pulmonary hypertension
PPTX
Pericarditis
PPT
Congestive Heart Failure
PPTX
Heart failure
PPTX
Cardiac tamponade
PPTX
Pulmonary embolism
PPTX
heart failure
PPTX
Congenital heart disease
PPT
Congestive heart failure
PPTX
Heart failure
PPTX
Congestive Heart Failure (CHF)
PPT
1. heart pathology; heart failure
Pulmonary hypertension
Heart failure
Heart failure
Heart failure: Basic Cocepts
Heart Failure
Heart failure
Heart failure management
Pulmonary hypertension
Pericarditis
Congestive Heart Failure
Heart failure
Cardiac tamponade
Pulmonary embolism
heart failure
Congenital heart disease
Congestive heart failure
Heart failure
Congestive Heart Failure (CHF)
1. heart pathology; heart failure
Ad

Similar to Heart Failure (20)

PPTX
Heart failure update 2012
PPTX
Congestive heart failure final
PPTX
cardio emergencies I.pptx
PPTX
HEART FAILURE UPDATE By Prof Okpara.pptx
PPTX
MANAGEMENT OF HEART FAILURE BY DR MARDHAY_020924.pptx
PPTX
Heart failure
PPTX
Congestive heart failure in an orthopedic patient
PPTX
HEART FAILURE PROF I.C OKPARA UPDATED.pptx
PPTX
Cardiomyopathies
PPT
Htn Heart Failure 2010
PPT
Htn Heart Failure 2010
PPTX
Heart failure
PPTX
Pulmonary hypertension.pptx
PPTX
cardiomyopathy seminar.pptx
PPTX
Congestive Cardiac Failure presentation and diagnosis
PPTX
Congestive Heart Failure.pptx
PPT
Congestive heart failure basics
PPTX
Heart failure 2019
PPTX
Cardiac Failure Sem 5.pptx
Heart failure update 2012
Congestive heart failure final
cardio emergencies I.pptx
HEART FAILURE UPDATE By Prof Okpara.pptx
MANAGEMENT OF HEART FAILURE BY DR MARDHAY_020924.pptx
Heart failure
Congestive heart failure in an orthopedic patient
HEART FAILURE PROF I.C OKPARA UPDATED.pptx
Cardiomyopathies
Htn Heart Failure 2010
Htn Heart Failure 2010
Heart failure
Pulmonary hypertension.pptx
cardiomyopathy seminar.pptx
Congestive Cardiac Failure presentation and diagnosis
Congestive Heart Failure.pptx
Congestive heart failure basics
Heart failure 2019
Cardiac Failure Sem 5.pptx
Ad

More from meducationdotnet (20)

PPTX
PPT
Spondylarthropathy
PPT
Diagnosing Lung cancer
PPT
Eczema Herpeticum
PPT
The Vagus Nerve
PPT
Water and sanitation and their impact on health
PPT
The ethics of electives
PPT
Intro to Global Health
PPT
WTO and Health
PPT
Globalisation and Health
PPT
Health Care Worker Migration
PPT
International Institutions
PDF
Haemochromotosis brief overview
PDF
Ascities overview
PDF
Overview of the Liver
PDF
Overview of Antidepressants
PPT
Gout Presentation
PDF
Review of orthopaedic services: Prepared for the Auditor General for Scotland...
PPT
Sugammadex - a revolution in anaesthesia?
PPT
Ophthamology Revision
Spondylarthropathy
Diagnosing Lung cancer
Eczema Herpeticum
The Vagus Nerve
Water and sanitation and their impact on health
The ethics of electives
Intro to Global Health
WTO and Health
Globalisation and Health
Health Care Worker Migration
International Institutions
Haemochromotosis brief overview
Ascities overview
Overview of the Liver
Overview of Antidepressants
Gout Presentation
Review of orthopaedic services: Prepared for the Auditor General for Scotland...
Sugammadex - a revolution in anaesthesia?
Ophthamology Revision

Heart Failure

  • 1. Heart Failure Prepared by: malek ahmad University of Malaya
  • 2. Outline Definition and Epidemiology Pathophysiology Aetiological factors and Risk factors Clinic al manifestation Investigation Differential diagnosis Management and treatment Complication and prognosis
  • 3. Definition • Inability in which heart cannot provide sufficient cardiac output to vital organ to satisfy the metabolic body needs or only can do so with filling pressure are higher than normal • Due to any structural or functional cardiac abnormalities • Can be divided to LVF , RVF • Always cause circulatory failure Epidemiology • Num 1 cause of hospitalization among Medicare patients • Cause more hospitalization than all form of cancer combined
  • 6. Terms • Deterioration of myocardial contraction function Systolic dysfunction • Normal contraction but abnormal relaxation Diastolic dysfunction • Inadequate CO Forward failure • Congestion of venous system Backward failure • Low CO and fails to increase normally with exertion Low-output failure • Greatly increase tissue demands result to failure High-output failure • Dilated ventricle able to maintain CO at level that meets body needsCompensated HF • Dilated ventricle unable to maintain and propel sufficient blood at level that meets body needsDecompensated HF
  • 8. Mechanism of adaptation • SNS>NA>Incrs HR, Incrs contractality, VasoC • Activation of RAAS • ANP>VasoD, natriuresis, diuresis Activation of neurohormonal system • Incrs EDV> Incrs EDP > muscle fibers strech > Incrs cardiac chamber V > contract more forcibly • However, incrs dilatation>incrs ventricular wall tension >incrs O2 demand Frank-starling mechanism (heamodynamic changes) • Pressure overload>incrs fiber diameter>concenteric hyperthrophy (incrs wall thckness w/o incrs chamber size) • Volume overload>incrs fiber length>eccenteric hyperthrophy>incrs heart size, incrs wall thickness Myocardial structural changes (cellular)
  • 9. Aetiological causes • Structural abnormalities (congenital /acquired) that affect the circulation, pericardium, myocardium, valves. Underlying causes • Biochemical n physiological mechanism, increased (increased hemodynamic burden n reduce O2delivery) Fundamental causes Precipitating causes
  • 10. Underlying causes • CAD , DM , HPT , VHD , arrythmias, infection n inflamation, conegital , drug induced , idiopathicSystolic heart failure • CAD , DM , HPT , VHD , hyperthropic cardiomyopathy, restrictive cardiomyopathy (amyloidosis) , pericarditisDiastolic heart failure • Acute MR/AR , MI , Myocarditis , arrythmias, drugs induced , sepsisAcute heart failure • Anemia, hyperthyroid, pagets, GN, multiple myoloma, carcinoid syndrome, polychaethemia vera High output heart failure • LVD , CAD , pulmonary HPT , PS , pulmonary embolism , chronic pulmonary disease , neuromuscular dsRight heart failure
  • 11. Precipitating causes Recurrent or continued coronary ischaemia Recurrent myocardial infarction Hypokalaemia, hypomagnesaemia, hyperkalaemia Psychotropic drugs-for example, tricyclic antidepressants Digoxin (leading to toxicity) Antiarrhythmic drugs that may be cardiodepressant (negative inotropism) and proarrhythmic
  • 12. Left heart failure IHD Systemic HPT Mitral/aortic valve disease Primary disease of myocardium Right heart failure LHF Pulmonary congestion Elevation of pulmonary arterial pressure •Intrinsic disease of lung parenchyma and/ or pulmonary vasculature (cor pulmonale) •Primary pulmonic/ tricuspid valve disease •Congenital-L to R shunt Isolated RHF
  • 13. NYHA classification of HF •No limitation in physical activity despite presence of heart disease. This can be suspected only if there is a history of heart disease which is confirmed by investigations - for example, echocardiography Class I: asymptomatic •Slight limitation in physical activity. More strenuous activity causes shortness of breath - for example, walking on steep inclines and several flights of steps. Patients in this group can continue to have an almost normal lifestyle and employment Class II: mild •More marked limitation of activity which interferes with work. Walking on the flat produces symptoms Class III: moderate •Unable to carry out any physical activity without symptoms. Patients are breathless at rest and mostly houseboundClass IV: severe
  • 14. Clinical manifestation Left Heart failure Dyspnoea Cough- fluid transudation onto airspace Orthopnoea-increase Venous Return PND Others-cadiomegaly,tachy,s3, fine rales (respiration thru edematous pulmonary alveoli, MR, systolic murmur, AF Right heart failure Systemic and portal venous congestion Hepatosplenomegaly Peripheral edema Pleural effusion Ascites
  • 16. Framingham Systems major PND , neck vein distyensiom Rales, cardiomegaly S3 gallop, acute PE CVP greater than 16cm H2O Hepatojugular reflux PE, visceral congestion Weight loss 4.5 in 5d minor Bilateral ankle edema Nocturnal cough Dyspnoea on ordinary exertion tachycardia Pleural effusion To diagnose HF = 2major / 1major+2minor
  • 17. Investigation • Established baselineFBC , electrolyte(K+) , RFT, LFT • Biomarker for heart failure and reflects the myocyte stretch and exclude other diagnosisBNP • Alveolar oedema, kerley B lines , cardiomegaly, dilated upper lobe vessels , pleural effusionCRX • Indicate the cause • Confirm the presence or absence of LV dysfunctionEcho • Indicate the cause, look sign of ischemia, MI , ventricular hyperthrophyECG
  • 18. Management and treatment Acute heart failure Sit upright O2n 100% if no lung disease IV acces and monitor ECG treat arrythmia Ix and dimorphine , frusemide , GTN spray Necessary IX, history and examination Chronic heart failure Stop smoking, eat less salt, optimize weight n nutrition Treat cause (arrhythmia, valve disease) Treat exacerbating factor s(anemia , thyroid disease) Avoid exacerbating factors, NSAIDs • Diuretics- furosemide, spironolactone • ACE inhibitor – angitensin receptor blocker • B-blocker – carvedilol • Digoxin • Vasodilator - hydralazine Drugs
  • 19. Complication • Unintentional rapid weight loss (a loss of at least 7.5% of normal weight within 6 months) Cardiac cachexia • Due to poor blood supply Impaired kidney function • Malabsorption • Hepatic congestion and dysfunction GIT • AF, ventricular arrhythmiasArrhythmias • Stroke, peripheral and pulmonary embolism, DVT, Thromboembolism Prognosis Better in asymptomatic left ventricular dysfunction than that in those whose left ventricular dysfunction is symptomatic. NYHA class, left ventricular ejection fraction, and neurohormonal status Dependent on severity, age, and sex, with a poorer prognosis in male patients
  • 20. Predictor of poor prognosis High NYHA functional class Reduced left ventricular ejection fraction Raised plasma catecholamine and natriuretic peptide concentrations, Reduced sodium concentration Third heart sound Diabetes mellitus